SEATTLE Neurim Pharmaceuticals announced that Circadin in 2-mg strength showed long-term efficacy and safety in elderly patients during a large-scale phase three study. Circadin is a well-known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results